Beta-1 and beta-2 adrenergic receptors — Drug Target

13 drugs 6 marketed 6 in Phase 3

All drugs that target Beta-1 and beta-2 adrenergic receptors — marketed and clinical-stage. Includes 7 drug classes acting on this target.

Drug classes

Beta-adrenergic antagonist · Beta-adrenergic antagonist (non-selective) · Beta-adrenergic antagonist (non-selective beta-blocker) · Non-selective beta-adrenergic antagonist (beta-blocker) · Beta-adrenergic receptor antagonist (non-selective beta-blocker) · Non-selective beta-adrenergic antagonist · Non-selective beta-blocker

Marketed (6)

Phase 3 pipeline (6)

Phase 2 pipeline (1)